Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Hypertrophic cardiomyopathy is a common complication of Friedreich's ataxia (FRDA). Histological sections reveal abnormal cardiomyocytes, muscle fiber necrosis, reactive inflammation, and increased endomysial connective tissue. Scattered muscle fibers display perinuclear collections of minute iron-positive granules that lie in rows between myofibrils. Frataxin deficiency in FRDA causes mitochondrial iron dysmetabolism. We studied total iron and the iron-related proteins ferritin, mitochondrial ferritin, divalent metal transporter 1 (DMT1), and ferroportin in FRDA hearts by biochemical and histological techniques. Total iron in the left ventricular wall of FRDA patients (30.7+/-19.3 mg/100 g dry weight) was not significantly higher than normal (31.3+/-24.1 mg/100 g dry weight). Similarly, cytosolic holoferritin levels in FRDA hearts (230+/-172 microg/g wet weight) were not significantly elevated above normal (148+/-86 microg/g wet weight). The iron-positive granules exhibited immunoreactivity for cytosolic ferritin, mitochondrial ferritin, and ferroportin. Electron microscopy showed enhanced electron density of mitochondrial deposits after treatment with bismuth subnitrate supporting ferritin accumulation. The inflammatory cells in the endomysium were reactive for CD68, cytosolic ferritin, and the DMT1 isoform(s) translated from messenger ribonucleic acids containing iron-responsive elements (DMT1+). Progressive cardiomyopathy in FRDA is the likely result of iron-catalyzed mitochondrial damage followed by muscle fiber necrosis and a chronic reactive myocarditis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“clinical symptoms include cardiac hypertrophy [1128] and (pre-)diabetes [1129], consistent with the general thesis described here that all are in part manifestations of iron dysregulation, and in which suitable chelation may be beneficial [1130,1131]”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1128]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“Total protein was determined according to Bradford (21).”
MethodCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 1×
“This circulating liver-derived peptide hormone causes internalization and degradation of ferroportin (26,39).”
BackgroundCloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166 · cited 1×
“In theory, iron excess should cause a more rapid turnover of DMT1+ mRNA due to the presence of an IRE in the 3’-UTR (33).”
BackgroundFriedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786 · cited 2×
“In the more recent cases examined in Albany, New York (‘A’ in Table I) and whenever stored frozen tissue of older cases was available, FRDA was confirmed by polymerase chain reaction with specific deoxyoligonucleotide primers (4,16), agarose gel electrophoresis, and sizing of deoxyribonucleic acid (DNA) fragments cont…”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
Dürr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.-L., Brice, A., & Koenig, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351601 · Cited by 1,071 · cited 1×
“In patients with relatively short expansions, frataxin deficiency is not complete, and the clinical course is more benign (5).”
BackgroundAconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
Rötig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., & Rustin, P. (1997) · Nature Genetics · doi:10.1038/ng1097-215 · Cited by 991 · cited 1×
“In biopsy samples of FRDA heart, the activities of ISC-requiring complexes I, II, and III of the electron transport chain, and of aconitase, are impaired (7).”
Background
Research works printed but not linked: 2
- Ruggeri, G. and Iacobello, C. and Albertini, A. and (1984) Studies of human isoferritins in tissues and body fluids.. In Ferritins and isoferritins as biochemical markers. ( pp. 67 - 78 ). Amsterdam; New York : Elsevier.
- Nicolas, G. and Bouhour, J. B. and Delajartre, A. and (1971) Myocardiopathie secondaire à l'hémochromatose idiopathique. Arch Mal Coeur Vaiss, 64, pp. 1533 - 46.
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“As well as the neurodegeneration and measurable iron deposition, clinical symptoms include cardiac hypertrophy [1012] and (pre-)diabetes [1013], consistent with the general thesis described here that all are in part manifestations of iron dysregulation, and in which suitable chelation may be beneficial [1014; 1015] (b…”
BackgroundFriedreich's ataxia: Pathology, pathogenesis, and molecular genetics
Koeppen, A. H. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.01.010 · Cited by 447
“Some of the observations are at variance with the analysis of iron-handling proteins in the hearts of patients with FRDA [56].”
BackgroundResultInfluentialSelf-citationIron–sulfur cluster biogenesis and human disease
Rouault, T. A., & Tong, W. H. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.05.008 · Cited by 385
“observed in the hearts and brains of FRDA patients [ 35 ] (Box 1) and heart-specific knockout mouse models [36].”
BackgroundMitochondria as a Therapeutic Target in Heart Failure
Bayeva, M., Gheorghiade, M., & Ardehali, H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1021 · Cited by 332
Arosio, P., & Levi, S. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.02.005 · Cited by 321
“ferritin-loaded mitochondria [120].”
Friedreich Ataxia: Neuropathology Revised
Koeppen, A. H., & Mazurkiewicz, J. E. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827e5762 · Cited by 261
“Electron microscopy of an FRDA heart after enhancement of ferritin by bismuth subnitrate localized reaction product to mitochondria; and an antibody to mitochondrial ferritin revealed reactive granules in a small percentage of fibers (49).”
BackgroundInfluentialSelf-citationOxidative Stress and the Homeodynamics of Iron Metabolism
Bresgen, N., & Eckl, P. (2015) · Biomolecules · doi:10.3390/biom5020808 · Cited by 247
“found in mitochondria of Ftx-deficient cardiomyocytes of FRDA patients, which points at the role of iron/ferritin derived mitochondrial damage in cardiomyocyte cell death [259].”
BackgroundPerdomini, M., Belbellaa, B., Monassier, L., Reutenauer, L., Messaddeq, N., Cartier, N., Crystal, R. G., Aubourg, P., & Puccio, H. (2014) · Nature Medicine · doi:10.1038/nm.3510 · Cited by 239
The role of iron in mitochondrial function
Levi, S., & Rovida, E. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.09.008 · Cited by 195
Friedreich Ataxia: Molecular Mechanisms, Redox Considerations, and Therapeutic Opportunities
Santos, R., Lefevre, S., Sliwa, D., Seguin, A., Camadro, J.-M., & Lesuisse, E. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3015 · Cited by 192
“Iron accumulation has been found in the heart (36, 177, 206, 272), liver (36), and spleen (36), but not in the DRG, spinal cord, skeletal muscle, cerebellum, peripheral nerves, or pancreas (36).”
Hick, A., Wattenhofer-Donzé, M., Chintawar, S., Tropel, P., Simard, J. P., Vaucamps, N., Gall, D., Lambot, L., André, C., Reutenauer, L., et al. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010900 · Cited by 154
“These findings parallel the mitochondria damages seen in cardiac tissues from FRDA patients and from FRDA mouse models (Michael et al., 2006; Seznec et al., 2005) and are characteristic for respiration-compromised mitochondria.”
Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders
Mena, N. P., Urrutia, P. J., Lourido, F., Carrasco, C. M., & Núñez, M. T. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.001 · Cited by 153
“Mitochondrial iron accumulation in FA has been demonstrated mostly in the heart and several other systemic tissues (Bradley et al., 2000; Delatycki et al., 1999; Michael et al., 2006; Puccio et al., 2001), whereas evidence for iron accumulation in neuronal mitochondria is conspicuously absent.”
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
Ast, T., Meisel, J. D., Patra, S., Wang, H., Grange, R. M. H., Kim, S. H., Calvo, S. E., Orefice, L. L., Nagashima, F., Ichinose, F., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.045 · Cited by 155
Iron dysregulation in movement disorders
Dusek, P., Jankovic, J., & Le, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.054 · Cited by 169
The dentate nucleus in Friedreich’s ataxia: the role of iron-responsive proteins
Koeppen, A. H., Michael, S. C., Knutson, M. D., Haile, D. J., Qian, J., Levi, S., Santambrogio, P., Garrick, M. D., & Lamarche, J. B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0220-y · Cited by 174
“For sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting, the heattreated supernatants were concentrated by centrifugation through ultraWltration membranes with a molecular cut-oV of 100 kDa as described before [22].”
BackgroundMethodSelf-citationMartelli, A., & Puccio, H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00130 · Cited by 147
“Iron metabolism dysregulation was also observed in heart autopsies of individuals with FRDA (Michael et al., 2006; Ramirez et al., 2012).”
BackgroundResultCampanella, A., Rovelli, E., Santambrogio, P., Cozzi, A., Taroni, F., & Levi, S. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn308 · Cited by 162
“The presence of FtMt was documented in the heart of one FRDA patient (22) and it was found to be upregulated in two FRDA fribroblast cell lines (34) suggesting that cells could respond to frataxin deficiency promoting FtMt expression.”
BackgroundCerebral Iron Deposition in Neurodegeneration
Dusek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. O. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 159
Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia
Li, K., Besse, E. K., Ha, D., Kovtunovych, G., & Rouault, T. A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn127 · Cited by 141
“develops in the heart and central nervous system (4)(5)( 6 ).”
BackgroundHaugen, A. C., Di Prospero, N. A., Parker, J. S., Fannin, R. D., Chou, J., Meyer, J. N., Halweg, C., Collins, J. B., Durr, A., Fischbeck, K., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000812 · Cited by 107
“There is good evidence to suggest that hypertrophic cardiomyopathy, which leads to the death of most FRDA patients, is probably a consequence of iron-catalyzed Fenton chemistry causing damage to mitochondrial macromolecules followed by muscle fiber necrosis and a chronic reactive myocarditis [24].”
BackgroundThe pathology of superficial siderosis of the central nervous system
Koeppen, A. H., Michael, S. C., Li, D., Chen, Z., Cusack, M. J., Gibson, W. M., Petrocine, S. V., & Jiang, Q. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0421-z · Cited by 151
“The technique was described in detail from the authors’ laboratory [16, 21].”
BackgroundMethodResultSelf-citationThe Pathogenesis of Cardiomyopathy in Friedreich Ataxia
Koeppen, A. H., Ramirez, R. L., Becker, A. B., Bjork, S. T., Levi, S., Santambrogio, P., Parsons, P. J., Kruger, P. C., Yang, K. X., Feustel, P. J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116396 · Cited by 124
“Diagnostic endomyocardial biopsies in young FA patients are no longer justified, but it is known that cardiac Fe accumulates very early in the disease (FA11, Table 1 and [5]).”
InfluentialSelf-citationIron chelation in the treatment of neurodegenerative diseases
Dušek, P., Schneider, S. A., & Aaseth, J. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.03.010 · Cited by 144
“Abnormal iron granules were detected in cardiomyocytes in FRDA while the total iron concentration was not different from that of control cases [95].”
BackgroundThe dorsal root ganglion in Friedreich’s ataxia
Koeppen, A. H., Morral, J. A., Davis, A. N., Jiang, Q., Petrocine, S. V., Knutson, M. D., Gibson, W. M., Cusack, M. J., & Li, D. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0589-x · Cited by 135
“The effect of frataxin deficiency on iron-responsive proteins in DRG, DR, and VR will have to be studied by quantitative biochemical methods such as enzymelinked immunosorbent assays and Western blotting [17, 23 ].”
BackgroundMethodInfluentialSelf-citationPousset, F., Legrand, L., Monin, M., Ewenczyk, C., Charles, P., Komajda, M., Brice, A., Pandolfo, M., Isnard, R., du Montcel, S. T., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1855 · Cited by 132
Iron–sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia
Vaubel, R. A., & Isaya, G. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.003 · Cited by 122
“Similarly, total iron content was not significantly higher in the left ventricle of FRDA patients compared to controls (Michael et al., 2006), however, iron deposits were observed inside FRDA cardiomyocytes (Koeppen, 2011; Lamarche et al., 1980; Michael et al., 2006) and electron-dense inclusions…”
BackgroundInfluentialIron–Sulfur Clusters: Biogenesis, Molecular Mechanisms, and Their Functional Significance
Xu, X. M., & Møller, S. G. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3259 · Cited by 128
“Frataxin deficiency also leads to iron accumulation in mitochondria in heart and brain tissue (189), and this accumulation may lead to mitochondrial damage by iron-catalyzed oxidation (15). ciency of human [Fe-S] assembly and cellular iron homeostasis (46, 247, 335, 337).”
Cardiomyopathy in Friedreich Ataxia: Clinical Findings and Research
Payne, R. M., & Wagner, G. R. (2012) · Journal of Child Neurology · doi:10.1177/0883073812448535 · Cited by 125
Friedreich's ataxia: Past, present and future
Marmolino, D. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.04.001 · Cited by 123
“Sections illustrated in B–Ewere counterstainedwith permission from Michael et al., 2006). deficiency.”
BackgroundPharmacological therapeutics in Friedreich ataxia: the present state
Strawser, C. J., Schadt, K. A., Hauser, L. A., McCormick, A., Wells, M., Larkindale, J., Lin, H., & Lynch, D. R. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1356721 · Cited by 118
Cardiac Phenotypes in Hereditary Muscle Disorders
Arbustini, E., Toro, A. D., Giuliani, L., Favalli, V., Narula, N., & Grasso, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2182 · Cited by 114
Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
Chandran, V., Gao, K., Swarup, V., Versano, R., Dong, H., Jordan, M. C., & Geschwind, D. H. (2017) · eLife · doi:10.7554/elife.30054 · Cited by 114
“Another prominent feature of Fxn deficiency mouse and FRDA patients is iron accumulation and deficiency in activity of the iron-sulfur cluster dependent enzyme, aconitase, in cardiac muscle ( Puccio et al., 2001 ; Ro¨tig et al., 1997 ; Delatycki et al., 1999 ; Michael et al., 2006 ).”
BackgroundMitochondrial pathophysiology in Friedreich's ataxia
González‐Cabo, P., & Palau, F. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12303 · Cited by 110
“It has been proposed that such deposits may contain cytosolic and mitochondrial ferritin (Michael et al. 2006; Koeppen 2011).”
BackgroundLlorens, J. V., Soriano, S., Calap-Quintana, P., González‐Cabo, P., & Moltó, M. D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00075 · Cited by 99
Iron, oxidative stress, and redox signaling in the cardiovascular system
Gudjoncik, A., Guénancia, C., Zeller, M., Cottin, Y., Vergely, C., & Rochette, L. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400036 · Cited by 93
“[78] Michael, S.”
BackgroundFrataxin deficiency induces Schwann cell inflammation and death
Lu, C., Schoenfeld, R. A., Shan, Y., Tsai, H.-J., Hammock, B. D., & Cortopassi, G. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.011 · Cited by 94
“In Friedreich's ataxia patients, microscopic examinations of autopsied heart samples have revealed evidences of myocarditis with leukocyte infiltrations [41-43], suggesting that inflammation may play a role in the progressive cardiomyopathy in FRDA.”
Iron Regulatory Protein 1 Sustains Mitochondrial Iron Loading and Function in Frataxin Deficiency
Martelli, A., Schmucker, S., Reutenauer, L., Mathieu, J. R. R., Peyssonnaux, C., Karim, Z., Puy, H., Galy, B., Hentze, M. W., & Puccio, H. M. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.010 · Cited by 87
“FRDA is also characterized by altered cellular iron metabolism with mitochondrial iron accumulation (Michael et al., 2006; Puccio et al., 2001).”
BackgroundMartelli, A., Napierala, M., & Puccio, H. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008706 · Cited by 73
“Although the role of oxidative stress in pathology remains an open controversial question, a clear iron dysregulation (mainly illustrated by mitochondrial iron accumulation) is observed in FRDA (Lamarche et al., 1993; Michael et al., 2006; Koeppen et al., 2007).”
BackgroundChen, K., Lin, G., Haelterman, N. A., Ho, T. S.-Y., Li, T., Li, Z., Duraine, L., Graham, B. H., Jaiswal, M., Yamamoto, S., et al. (2016) · eLife · doi:10.7554/elife.16043 · Cited by 81
“Loss of yeast frataxin homolog results in iron accumulation (Babcock et al., 1997), and this phenotype has also been reported in cardiac muscles of a Fxn deficiency mouse and FRDA patients (Koeppen, 2011; Lamarche et al., 1980; Michael et al., 2006; Puccio et al., 2001).”
BackgroundHigh Levels of Frataxin Overexpression Lead to Mitochondrial and Cardiac Toxicity in Mouse Models
Belbellaa, B., Reutenauer, L., Messaddeq, N., Monassier, L., & Puccio, H. M. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.08.018 · Cited by 84
“The bismuth sodium tartrate staining of ferritin was performed as described previously.(27,76)”
MethodHeme Levels Are Increased in Human Failing Hearts
Khechaduri, A., Bayeva, M., Chang, H.-C., & Ardehali, H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.012 · Cited by 80
Martín, M., Colman, M. J. R., Gomez‐Casati, D. F., Lamattina, L., & Zabaleta, E. J. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.039 · Cited by 82
Mitochondrial Iron Metabolism: The Crucial Actors in Diseases
Duan, G., Li, J., Duan, Y., Zheng, C., Guo, Q., Li, F., Zheng, J., Yu, J., Zhang, P., Wan, M., et al. (2022) · Molecules · doi:10.3390/molecules28010029 · Cited by 69
“Recent work in patients [63] and in mouse models [64,65] provides evidence that this disease is characterized by significant accumulation of iron inside the mitochondria, extensive mitochondrial dysfunction, and oxidative damage [42,66].”
BackgroundThe Cerebellum, Cerebellar Disorders, and Cerebellar Research—Two Centuries of Discoveries
Manto, M. U. (2008) · The Cerebellum · doi:10.1007/s12311-008-0063-7 · Cited by 76
Advancements in the pathophysiology of Friedreich’s Ataxia and new prospects for treatments
Babady, N. E., Carelle, N., Wells, R. D., Rouault, T. A., Hirano, M., Lynch, D. R., Delatycki, M. B., Wilson, R. B., Isaya, G., & Puccio, H. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.05.009 · Cited by 73
Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia
Anzovino, A., Chiang, S., Brown, B. E., Hawkins, C. L., Richardson, D. R., & Huang, M. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.021 · Cited by 71
Multicellular models of Friedreich ataxia
Puccio, H. M. (2009) · Journal of Neurology · doi:10.1007/s00415-009-1004-1 · Cited by 66
Cerebellar pathology in Friedreich's ataxia: Atrophied dentate nuclei with normal iron content
Solbach, K., Kraff, O., Minnerop, M., Beck, A., Schöls, L. J., Gizewski, E. R., Ladd, M. E., & Timmann, D. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.08.018 · Cited by 66
“…in brain and heart tissue of FA patients (Lamarche et al., 1980), there is also evidence in FA patients of normal absolute iron levels in the DN (Koeppen et al., 2007), dorsal root ganglia (Koeppen et al., 2009), fibroblasts (Delatycki et al., 1999), and the heart (Michael et al., 2006).”
Novel Frataxin Isoforms May Contribute to the Pathological Mechanism of Friedreich Ataxia
Xia, H., Cao, Y., Dai, X., Marelja, Z., Zhou, D., Mo, R., Al‐Mahdawi, S., Pook, M. A., Leimkühler, S., Rouault, T. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047847 · Cited by 64
Molecular and Functional Alterations in a Mouse Cardiac Model of Friedreich Ataxia
Huang, M., Sivagurunathan, S., Ting, S., Jansson, P. J., Austin, C., Kelly, M., Semsarian, C., Zhang, D., & Richardson, D. R. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.032 · Cited by 63
“39 In the KO mice, the onset of cardiomyocyte degeneration and interstitial fi brosis was fi rst observed at 6 weeks of age (Figure 2K).”
BackgroundIncreased Heme Levels in the Heart Lead to Exacerbated Ischemic Injury
Sawicki, K. T., Shang, M., Wu, R., Chang, H., Khechaduri, A., Sato, T., Kamide, C., Liu, T., Prasad, S. V. N., & Ardehali, H. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002272 · Cited by 63
“hereditary hemochromatosis leads to the development of cardiomyopathy,(12) and patients with Friedrich’s ataxia develop progressive and lethal cardiomyopathy that is characterized by mitochondrial accumulation of iron and extensive oxidative damage.(13,14) Furthermore, cardiomyopathy in thalassemia major patients with…”
BackgroundFixing frataxin: ‘ironing out’ the metabolic defect in Friedreich's ataxia
Anzovino, A., Lane, D. J. R., Huang, M. L., & Richardson, D. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12470 · Cited by 56
“Interestingly, examination of heart samples from FRDA patients exhibited evidence of myocarditis with leukocyte infiltrations (Hejtmancik et al., 1949; Michael et al., 2006) and also presents a case for the role of inflammation in the progression of cardiomyopathy in FRDA.”
BackgroundIron Withholding: A Defense Against Disease
Weinberg, E. D., & Miklossy, J. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13409 · Cited by 53
Relation of Cytosolic Iron Excess to Cardiomyopathy of Friedreich's Ataxia
Ramirez, R. L., Qian, J., Santambrogio, P., Levi, S., & Koeppen, A. H. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.018 · Cited by 59
Self-citationSeco-Cervera, M., González‐Cabo, P., Pallardó, F. V., Mateo, C. R., & García‐Giménez, J. L. (2020) · Antioxidants · doi:10.3390/antiox9121257 · Cited by 59
“In this regard, accumulation of IRPs such as cytosolic ferritin, mitochondrial ferritin, and ferroportin have been found in heart tissue of FRDA patients [139].”
Lee, Y.-K., Ho, P. W., Schick, R., Lau, Y., Lai, W., Zhou, T., Li, Y., Ng, K., Ho, S. L., Esteban, M. A., et al. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1414-x · Cited by 58
“Even in the hearts of patients with FRDA, iron accumulation has not been consistently demonstrated [21].”
Metal and complementary molecular bioimaging in Alzheimer's disease
Braidy, N., Poljak, A., Marjo, C. E., Rutlidge, H., Rich, A. M., Jayasena, T., Inestrosa, N. C., & Sachdev, P. S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00138 · Cited by 57
Sphingolipids in neurodegenerative diseases
Pan, X., Dutta, D., Lu, S., & Bellen, H. J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1137893 · Cited by 54
Chiang, S., Kalinowski, D. S., Jansson, P. J., Richardson, D. R., & Huang, M. L.-H. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.002 · Cited by 50
Busi, M. V., & Gomez‐Casati, D. F. (2012) · IUBMB Life · doi:10.1002/iub.577 · Cited by 46
Martelli, A., Friedman, L. S., Reutenauer, L., Messaddeq, N., Perlman, S., Lynch, D. R., Fedosov, K., Schulz, J. B., Pandolfo, M., & Puccio, H. M. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009829 · Cited by 51
“These aggregates are reminiscent of the characteristic iron deposits identified in patients (Lamarche et al., 1993; Michael et al., 2006) and in the cardiac mouse model of FRDA (Puccio et al., 2001).”
BackgroundThe Neuropathology of Late-Onset Friedreich’s Ataxia
Koeppen, A. H., Morral, J. A., McComb, R. D., & Feustel, P. J. (2011) · The Cerebellum · doi:10.1007/s12311-010-0235-0 · Cited by 46
“Heart disease in FRDA evolves independently of the neurological manifestations of FRDA and may precede ataxia [6].”
Self-citationFrataxin deficiency in neonatal rat ventricular myocytes targets mitochondria and lipid metabolism
Òbis, È., Irazusta, V. P., Sanchís, D., Ros, J., & Tamarit, J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.016 · Cited by 49
Keeping heart homeostasis in check through the balance of iron metabolism
Vela, D. (2019) · Acta Physiologica · doi:10.1111/apha.13324 · Cited by 44
Chiang, S., Braidy, N., Maleki, S., Lal, S., Richardson, D. R., & Huang, M. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102038 · Cited by 42
“Considering that inappropriately bound iron is redox active and toxic [9,10], this could contribute to the redox dysregulation observed in the heart of FA patients [11].”
BackgroundThe heart in Friedreich's Ataxia: Basic findings and clinical implications
Payne, R. M. (2011) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2011.02.007 · Cited by 41
“This parallels exactly what is found in the human heart [38] and has strong clinical implications for patients with FA: left ventricular contractile function will ultimately decrease due to loss of contractile proteins and disruption”
Iron Homeostasis in Peripheral Nervous System, Still a Black Box?
Levi, S., & Taveggia, C. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5813 · Cited by 41
Wofford, J. D., Chakrabarti, M., & Lindahl, P. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.777201 · Cited by 39
Nachbauer, W., Boesch, S., Reindl, M., Eigentler, A., Hufler, K., Poewe, W. H., ̈scher, W. L., & Wanschitz, J. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825fed76 · Cited by 37
“Endocardial biopsies reveal abnormal cardiomyocytes, muscle fiber necrosis, reactive inflammation, and increased endomysial connective tissue (8).”
BackgroundXu, L., Sun, Z., Xing, Z., Liu, Y., Zhao, H., Tang, Z., Luo, Y., Hao, S., & Li, K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01333-9 · Cited by 35
Cardiovascular Research in Friedreich Ataxia
Payne, R. M. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.04.005 · Cited by 34
Hayashi, G., Shen, Y., Pedersen, T. L., Newman, J. W. I., Pook, M. A., & Cortopassi, G. A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu407 · Cited by 33
“There is clear evidence of inflammation in Friedreich’s autoptic hearts marked by cluster of differentiation 68 (CD68) positive cells (49); CD68 is a marker of microglial activation.”
BackgroundManagement and therapy for cardiomyopathy in Friedreich’s ataxia
Lynch, D. R., Regner, S. R., Schadt, K. A., Friedman, L. S., Lin, K. Y., & Sutton, M. G. S. J. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.57 · Cited by 33
Schreinemachers, D. M., & Ghio, A. J. (2016) · Environmental Health Insights · doi:10.4137/ehi.s36225 · Cited by 32
Ramachandra, C. J. A., Chua, J., Cong, S., Ja, K. P. M. M., SHIM, W. S. N., Wu, J. C., & Hausenloy, D. J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa125 · Cited by 33
Cardiomyopathy of Friedreich’s Ataxia (FRDA)
Payne, R. M., & Peverill, R. E. (2012) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-012-0808-7 · Cited by 32
Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases
Kolnagou, A., Kontoghiorghe, C. N., & Kontoghiorghes, G. J. (2014) · World Journal of Methodology · doi:10.5662/wjm.v4.i4.197 · Cited by 30
Perlman, S. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52014-2.00006-9 · Cited by 31
Kruger, P. C., Yang, K. X., Parsons, P. J., Becker, A. B., Feustel, P. J., & Koeppen, A. H. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.04.024 · Cited by 28
Self-citationCellular pathophysiology of Friedreich's ataxia cardiomyopathy
Lees, J. G., Напиерала, М., Pébay, A., Dottori, M., & Lim, S. Y. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.11.033 · Cited by 26
Genetic Infiltrative Cardiomyopathies
Sweet, M., Mestroni, L., & Taylor, M. R. G. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.12.003 · Cited by 25
Iron Pathophysiology in Friedreich’s Ataxia
Li, K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_7 · Cited by 25
Payne, R. M., Pride, P. M., & Babbey, C. M. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-9943-6 · Cited by 23
“proliferation, loss of contractile sarcomeres, and electron dense particles within mitochondria that may represent iron deposition [52].”
BackgroundDionisi, C., Chazalon, M., Rai, M., Keime, C., Imbault, V., Communi, D., Puccio, H. M., Schiffmann, S. N., & Pandolfo, M. (2022) · Brain Communications · doi:10.1093/braincomms/fcad007 · Cited by 20
SS-31 efficacy in a mouse model of Friedreich ataxia by upregulation of frataxin expression
Liu, Y., Cai, J., Shen, J., Dong, W., Li, X., Fang, M., Lin, Y., Liu, J., Ding, Y., Qiao, T., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab232 · Cited by 18
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia
Monda, E., Lioncino, M., Rubino, M., Passantino, S., Verrillo, F., Caiazza, M., Cirillo, A., Fusco, A., Fraia, F. D., Fimiani, F., et al. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.07.001 · Cited by 18
Wang, Q., Guo, L., Strawser, C. J., Hauser, L. A., Hwang, W., Snyder, N. W., Lynch, D. R., Mesaros, C., & Blair, I. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192779 · Cited by 18
FDX2 and ISCU Gene Variations Lead to Rhabdomyolysis With Distinct Severity and Iron Regulation
Montealegre, S., Lebigot, E., Debruge, H., Romero, N. B., Héron, B., Gaignard, P., Legendre, A., Imbard, A., Gobin, S., Lacène, E., et al. (2022) · Neurology Genetics · doi:10.1212/nxg.0000000000000648 · Cited by 17
“Its deficiency leads to ISC deficiency, mitochondrial dysfunction,(45) and major mitochondrial iron accumulation.(45,46) Because FXN binds ISCU(47) and stimulates persulfide transfer to ISCU,(48) it might act as a compensatory protein to fulfill the demand for Fe-S biogenesis, altered in case of ISCU deficiency.”
BackgroundDrosophila melanogasterModels of Friedreich’s Ataxia
Calap-Quintana, P., Navarro, J. A., González-Fernández, J., Martínez-Sebastián, M. J., Moltó, M. D., & Llorens, J. V. (2018) · BioMed Research International · doi:10.1155/2018/5065190 · Cited by 17
Bolotta, A., Abruzzo, P. M., Baldassarro, V. A., Ghezzo, A., Scotlandi, K., Marini, M., & Zucchini, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7623023 · Cited by 15
“Cardiac iron dysregulation was described in several disorders including FRDA, which is characterized by iron maldistribution within subcellular compartments, leading to mitochondrial iron accumulation and cytosolic iron depletion [5, 28, 41].”
Friedreich Ataxia and nephrotic syndrome: a series of two patients
Shinnick, J. E., Isaacs, C. J., Vivaldi, S., Schadt, K. A., & Lynch, D. R. (2016) · BMC Neurology · doi:10.1186/s12883-016-0526-2 · Cited by 14
“microarray analysis [11, 12].”
BackgroundRosa, S. A., Thomas, B., Pieroni, M., Maurizi, N., Zampieri, M., Cappelli, F., Marchi, A. G., Pradella, S., Cardim, N. M., Bogaert, J. G., et al. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02774-x · Cited by 12
Tissue Iron in Friedreich Ataxia
Koeppen, A. H. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2301004 · Cited by 10
Self-citationGenetic Determined Iron Starvation Signature in Friedreich's Ataxia
Grander, M., Haschka, D., Indelicato, E., Kremser, C., Amprosi, M., Nachbauer, W., Henninger, B., Stefani, A., Högl, B., Fischer, C., et al. (2024) · Movement Disorders · doi:10.1002/mds.29819 · Cited by 10
“7 The early observation of iron deposits in affected tissues 8-10 as well as of mitochondrial iron overload in experimental models of frataxin de fi ciency 11-13 raised the question whether iron dysregulation and toxic iron accumulation are relevant pathogenic mechanisms.”
Microvascular pathology in Friedreich cardiomyopathy.
Koeppen, A. H., Qian, J., Travis, A., Sossei, A. B., Feustel, P. J., & Mazurkiewicz, J. E. (2020) · PubMed · doi:10.14670/hh-18-132 · Cited by 10
Self-citationUncommon features in Cuban families affected with Friedreich ataxia
Mariño, T. C., González-Zaldívar, Y., Laffita‐Mesa, J. M., Almaguer-Mederos, L. E., Aguilera‐Rodríguez, R., Almaguer‐Gotay, D., Rodríguez‐Labrada, R., Canales‐Ochoa, N., MacLeod, P., & Velázquez‐Pérez, L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.045 · Cited by 9
Friedreich’s Ataxia: Case series and the Additive Value of Cardiovascular Magnetic Resonance
Mavrogeni, S. I., Giannakopoulou, A., Katsalouli, M., Pons, R. M., Papavasiliou, A., Kolovou, G. D., Noutsias, M., Papadopoulos, G., Karanasios, E., & Chrousos, G. P. (2019) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180373 · Cited by 9
“Progressive cardiomyopathy in FA is the end-point of iron-catalyzed mitochondrial damage, followed by muscle fiber necrosis and chronic reactive myocarditis [29].”
Long non-coding RNA TUG1 is downregulated in Friedreich’s ataxia
Koka, M., Li, H., Akther, R., Perlman, S., Wong, D. Y., Fogel, B. L., Lynch, D. R., & Chandran, V. (2024) · Brain Communications · doi:10.1093/braincomms/fcae170 · Cited by 8
Chelating Therapy in Metal Storage Diseases
Dušek, P., & Aaseth, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803072-1.00006-7 · Cited by 7
Talaverón-Rey, M., Reche-López, D., Povea-Cabello, S., Álvarez-Córdoba, M., Gómez-Fernández, D., Romero-González, A., Cilleros-Holgado, P., Romero-Domínguez, J. M., López-Cabrera, A., Piñero-Pérez, R., et al. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03990-z · Cited by 7
“In FRDA patients’samples, histological analysis suggested that mitochondrial ferritin might be involved in the formation of the iron-rich structures [63].”
Metadata
- Authors
- Michael, S., Petrocine, S. V., Qian, J., Lamarche, J. B., Knutson, M. D., Garrick, M. D., & Koeppen, A. H.
- Affiliations
- Veterans Health Administration (US)
- Albany Medical College (US)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- University of Florida (US)
- University at Buffalo, State University of New York (US)
- United States Department of Veterans Affairs (US)
- Corresponding author
- Koeppen, Arnulf H.
- Venue
- The Cerebellum
- Published
- 2006-12
- Volume
- 5
- Issue
- 4
- Pages
- 257-267
- ISSN
- 1473-4222 (ISSN-L)
- OpenAlex
- W2149278525
- Cited by
- 122
- References
- 52
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 8 · 2021: 5 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 7 · 2014: 9 · 2013: 9 · 2012: 13
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Cerebellum (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (R01DLK59794)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 065064, K01DK065064)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- Friedreich's ataxia, hypertrophic cardiomyopathy, frataxin deficiency, iron accumulation, ferritin, mitochondrial ferritin, DMT1, ferroportin, iron-responsive element, myocarditis, muscle fiber necrosis, bismuth subnitrate, mitochondrial damage
- MeSH terms
- Adult, Autopsy, Cardiomyopathy, Hypertrophic, Enzyme-Linked Immunosorbent Assay, Female, Ferritins, Friedreich Ataxia, Humans, Iron, Male, Middle Aged, Myocardium, Retrospective Studies, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.